Our Approach
Delivering complex generics with confidence
Our expertise spans the full product lifecycle; licensing, development, manufacturing, and distribution – providing our partners with a single, reliable point at each stage.
Part of an established international group, Siinovia is headquartered in Jersey (Channel Islands) with additional offices in London, focusing on delivering niche generic and value-added medicines to the UK, EU, North America and Australasian markets.
Our expertise spans the full product lifecycle; licensing, development, manufacturing, and distribution – providing our partners with a single, reliable point at each stage.
Innovation is central to our philosophy and drives our approach. We continuously refine formulations, optimise delivery systems, and streamline supply strategies to ensure high-quality medicines reach patients with specific and underserved therapeutic needs efficiently, safely, and reliably.
We apply fresh thinking to enhance product performance, build greater supply resilience and respond to the evolving needs of healthcare.
Our long-standing success over decades is built on trusted relationships with manufacturing partners, regulatory authorities, and healthcare stakeholders. Through transparent collaboration and a strong network of approved manufacturing facilities across Europe and beyond, we uphold the highest levels of regulatory compliance, product quality, and supply reliability.
Siinovia specialises in the development and registration of high value, technically demanding formulations and also pursues first file opportunities.
Access to both in-house and external regulatory, development and manufacturing capabilities in Europe and Asia.
Over 40 pharmaceutical products in various stages of development and registration.
